MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Parkinson’s Disease Dogs to assist Gait Impairment: A Pilot study of Patient Experience and Outcomes

    A. Gallagher, C. O'Keeffe, J. Inocentes, J. Liegey, J. Dowler, C. Fearon, T. Lynch (Dublin, Ireland)

  • Parkinson’s Disease Health Policy in 7 African Countries: Results of a Transforming Parkinson’s Care in Africa (TraPCAf) Review

    R. Morton, A. Rogers, H. Francis, M. Cham, J. Lumsdon, C. Dotchin, E. Hamid, A. Akpalu, S. Gugssa, B. Mushengezi, O. Ojo, N. Okubadejo, D. Sokhi, R. Walker, N. Fothergill-Misbah (Newcastle upon Tyne, United Kingdom)

  • Parkinson’s disease motor phenotypes delineated by pallidal and subthalamic neurophysiology and machine learning

    V. Lavu, P. Coutinho, J. Hilliard, K. Foote, C. de Hemptinne, J. Wong, K. Johnson (Gainesville, USA)

  • Parkinson’s disease overlapping with other neurodegeneration-case series with neuropathological description.

    L. Milanowski, A. Salinska, A. Acewicz, M. Grzegorczyk, S. Tarka, S. Szlufik, T. Wierzba-Bobrowicz, D. Koziorowski (Warsaw, Poland)

  • Parkinson’s disease Symptoms Mitigated by Photobiomodulation: The Potential of the Tryptophan Kynurenine Ratio as a Marker for Responsiveness to Therapy.

    A. Liebert, B. Bicknell (Wahroonga, Australia)

  • Parkinson’s Exercise Guidelines: From Outdated to Updated

    M. Rafferty, L. Hoffman, L. Krasucki, D. Corcos (Chicago, USA)

  • Parkinson’s Progression Markers Initiative (PPMI): A Biomarker Engine for Therapeutic Development for PD and Related Synucleinopathies

    B. Mcmahon, A. Videnovic, A. Siderowf, B. Mollenhauer, C. Tanner, C. Coffey, C. Stanley, D. Weintraub, D. Galasko, E. Flagg, E. Brown, K. Merchant, K. Kieburtz, K. Poston, K. Marek, K. Fabrizio, L. Chahine, M. Kuhl, M. Frasier, R. Dobkin, R. Alcalay, S. Chowdury, T. Simuni, T. Foroud, T. Sherer, T. Tropea (Boston, USA)

  • Parkinsonism after Post-Anoxic Brain Injury

    B. Petko, S. Factor, R. Tripathi (Atlanta, USA)

  • Parkinsonism Due to Delayed Neurotoxicity of CAR-T Therapy

    M. Murzello, A. Pena (Jacksonville, USA)

  • Parkinsonism following Chronic Disulfiram Overdose

    S. Ray, V. Kamath, B. Bairy (Bangalore, India)

  • « Previous Page
  • 1
  • …
  • 120
  • 121
  • 122
  • 123
  • 124
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley